| |
有關結核病的文獻
(有關資料只供參考，並非表示已包含所有有關結核病的文獻)
1995
- Kapur V, Li LL, Hamrick MR, Plikaytis BB, Shinnick TM,
Telenti A, Jacobs WR Jr, Banerjee A, Cole S, Yuen KY, et
al. Rapid Mycobacterium species assignment and unambiguous
identification of mutations associated with antimicrobial
resistance in Mycobacterium tuberculosis by automated DNA
sequencing. Arch Pathol Lab Med 1995;119:131-8.
- Yew WW, Chau CH, Wong PC, Lee J, Wong CF, Cheung SW, Chan
CY, Cheng AF. Ciprofloxacin in the management of pulmonary
tuberculosis in the face of hepatic dysfunction. Drugs Exp
Clin Res 1995;21:79-83.
- Chan CH, Lai CK, Leung JC, Ho AS, Lai KN. Elevated interleukin-2
receptor level in patients with active pulmonary tuberculosis
and the changes following anti-tuberculosis chemotherapy.
Eur Respir J 1995;8:70-3.
- Wong PC, Yew WW, Wong CF, Choi HY. Ethambutol-induced
pulmonary infiltrates with eosinophilia and skin involvement.
Eur Respir J 1995;8:866-8.
- Yew WW, Chau CH. Drug-resistant tuberculosis in the 1990s.
Eur Respir J 1995;8:1184-92.
- Dai DLK, LeeYC. Usefulness of the Mantoux test in screening
for active pulmonary tuberculosis in the Hong Kong elderly.
Hong Kong Med J 1995;1:195-200.
- Chong LY, Lo KK. Cutaneous tuberculosis in Hong Kong:
a 10-year retrospective study. Int J Dermat 1995;34:26-9.
- Yuen KY, Chan CM, Chan KS, Yam WC, Ho PL, Chau PY. IS6110
based amplityping assay and RFLP fingerprinting of clinical
isolates of Mycobacterium tuberculosis. J Clin Pathol 1995;48:924-8.
- Chan CH, Or KK, Cheung W, Woo J. Adverse drug reactions
and outcome of elderly patients on antituberculosis chemotherapy
with and without rifampicin. J Med 1995;26:43-52.
- Woo J, Chan C, Chan R, Cheung W, Or K, Chan K. Correlation
between steady-state plasma concentration of antituberculous
drugs and age, inclusion of rifampicin in the treatment
regimen, adverse drug reactions and other clinical parameters.
J Med 1995;26:279-94.
- Hosker HSR, Lam CW, Ng TK, Ma HK, Chan SL. The prevalence
and clinical significance of pulmonary infection due to
non-tuberculous mycobacteria in Hong Kong. Respir Med 1995;89:3-8.
- Ip MS, Yuen KY, Chiu EK, Chan JC, Lam WK, Chan TK. Pulmonary
infections in bone marrow transplantation: the Hong Kong
experience. Respiration 1995;62:80-3.
- Yew WW, Wong CF, Lee J, Wong PC, Chau CH. Do beta-lactam-beta-lactamase
inhibitor combinations have a place in the treatment of
multidrug-resistant pulmonary tuberculosis? Tuberc Lung
Dis 1995;76:90-2.
- Yew WW, Chau CH, Wong PC, Choi HY. Ciprofloxacin-induced
renal dysfunction in patients with mycobacterial lung infections.
Tuberc Lung Dis 1995;76:173-5.
- Yew WW, Lee J. Pathogenesis of cervical tuberculous lymphadenitis:
pathways to anatomic localization. Tuber Lung Dis 1995;76:275-6.
- Chan CH, Woo J, Or KK, Chan RC, Cheung W. The effect of
age on the presentation of patients with tuberculosis. Tuberc
Lung Dis 1995;76:290-4.
返回頁首
1994
- Yew WW, Wong PC, Lee J, Chau CH. Ofloxacin and pulmonary
tuberculosis. Chest 1994;105:1624.
- Yew WW, Wong PC, Lee J, Wong CF. Rapid diagnosis of smear-negative
pulmonary tuberculosis. Chest 1994;106:326-7.
- Wong CF, Yew WW. Ethambutol-induced neutropenia and eosinophilia.
Chest 1994;106:1638-9.
- Yew WW, Chau CH, Lee J, Leung CW. Cholestatic hepatitis
in a patient who received clarithromycin therapy for a Mycobacterium
chelonae lung infection. Clin Infect Dis 1994;18:1025-6.
- Yew WW, Chau CH, Tse LS. Does hospitalizing patients with
tuberculosis ensure compliance with drug regimens? Clin
Infect Dis 1994;19:554-5.
- Chan SL, Yew WW, Porter JHD, McAdam KPWJ, Allen BW, Dickinson
JM, Ellard GA, Mitchison DA. Comparison of Chinese and Western
rifapentines and improvement of bioavailability by prior
taking of various meals. Int J Antimicrob Agents 1994;3:267-74.
- Yew WW, Piddock LJ, Li MS, Lyon D, Chan CY, Cheng AF.
In-vitro activity of quinolones and macrolides against mycobacteria.
J Antimicrob Chemother 1994;34:343-51.
- Tsang DN, Li PC, Ho HF, Lai RW. Mycobacterial diseases and AIDS in Hong Kong. Journal of the Hong
Kong Medical Association 1994;46:102-5.
- Cheng AF, Li MS, Chan CY, Chan CH, Lyon D, Wise R, Lee
JC. Evaluation of three culture media and their combinations
for the isolation of Mycobacterium tuberculosis from pleural
aspirates of patients with tuberculous pleurisy. J Trop
Med Hyg 1994;97:249-53.
- Hoheisel G, Chan KM, Chan HS, Chan KS, Teschler H, Costobel
U. Endobronchial tuberculosis: diagnostic features and therapeutic
outcome. Respir Med 1994;88:593-7.
- Chan SL, Wong PC, Tam CM. 4-, 5- and 6-month regimens
containing isoniazid, rifampicin, pyrazinamide and streptomycin
for treatment of pulmonary tuberculosis under program conditions
in Hong Kong. Tuberc Lung Dis 1994;75:245-50.
- Chan KL, Chan HS, Lui SF, Lai KN. Recurrent acute pancreatitis
induced by isoniazid. Tuberc Lung Dis 1994;75:383-5
返回頁首
1993
- Tsui SY, Yew WW, Li MS, Chan CY, Cheng AF. Postantibiotic
effects of amikacin and ofloxacin on Mycobacterium fortuitum.
Antimicrob Agents Chemother 1993;37:1001-3.
- Yew WW, Wong CF, Wong PC, Lee J, Chau CH. Adverse neurological
reactions in patients with multidrug-resistant pulmonary
tuberculosis after coadministration of cycloserine and ofloxacin.
Clin Infect Dis 1993;17:288-9.
- Yew WW, Wong PC, Woo HS, Yip CW, Chan CY, Cheng FB. Characterization
of Mycobacterium fortuitum isolates from sternotomy wounds
by antimicrobial susceptibilities, plasmid profiles, and
ribosomal ribonucleic acid gene restriction patterns. Diagn
Microbiol Infect Dis 1993;17:111-7.
- Chan SL. Update on chemotherapy for tuberculosis. Hong
Kong Pract 1993;15:2448-53.
- Yew WW, Tam CM, Chan CY, Li MS, Cheng AF. Lack of activities
of amikacin and sulphamethoxazole against Mycobacterium
avium-intracellulare. Int J Clin Pharmacol Res 1993;13:65-8.
- Yuen KY, Chan KS, Chan CM, Ho BS, Dai LK, Chau PY, Ng
MH. Use of PCR in routine diagnosis of treated and untreated
pulmonary tuberculosis. J Clin Path 1993;46:318-22.
- Das S, Chan SL, Allen BW, Mitchison DA, Lowrie DB. Application
of DNA fingerprinting with IS986 to sequential mycobacterial
isolates obtained from pulmonary tuberculosis patients in
Hong Kong before, during and after short-course chemotherapy.
Tuberc Lung Disease 1993;74:47-5.
返回頁首
1992
- Woo J, Chan HS. Therapeutic problems in the management
of elderly patients with tuberculosis. Adverse Drug React
Toxicol Rev 1992;11:13-8.
- Hong Kong Chest Service/ Tuberculosis Research Centre,
Madras/ British Medical Research Council. A double-blind
placebo-controlled clinical trial of three antituberculosis
chemoprophylaxis regimens in patients with silicosis in
Hong Kong. Am Rev Respir Dis 1992;145:36-41.
- Yew WW, Lee J. Drug treatment of chronic tuberculous empyema.
Chest 1992;101:1741-2.
- Yew WW, Lau KS, Tse WK, Wong CF. Imipenem in the treatment
of lung infections due to Mycobacterium fortuitum and Mycobacterium
chelonae: further experience. Clin Infect Dis 1992;15:1046-7.
- Yew WW, Lee J, Wong PC, Kwan SY. Tolerance of ofloxacin
in the treatment of pulmonary tuberculosis in presence of
hepatic dysfunction. Int J Clin Pharmacol Res 1992;12:173-8.
- Woo J, Chan CH, Walubo A, Chan KK. Hydrazine--a possible
cause of isoniazid--induced hepatic necrosis. J Med 1992;23:51-9.
- Chan CHS, Chan RCY, Arnold M, Cheung H, Cheung SW, Cheng A. Bronchoscopy and tuberculostearic acid
assay in the diagnosis of sputum smear-negative pulmonary tuberculosis: a prospective study with the
addition of transbronchial biopsy. Q J Med 1992;82:15-23.
- Chan SL, Yew WW, Ma WK, Girling DJ, Aber VR, Felmingham
D, Allen BW, Mitchison DA. The early bactericidal activity
of rifabutin measured by sputum viable counts in Hong Kong
patients with pulmonary tuberculosis. Tuberc Lung Dis 1992;73:33-8.
- Hong Kong Chest Service/ British Medical Research Council.
A controlled study of rifabutin and an uncontrolled study
of ofloxacin in the retreatment of patients with pulmonary
tuberculosis resistant to isoniazid, streptomycin and rifampicin.
Tuberc Lung Dis 1992;73:59-67.
返回頁首
1991
- Hong Kong Chest Service/ Tuberculosis Research Centre,
Madras/ British Medical Research Council. A controlled clinical
comparison of 6 and 8 months of antituberculosis chemotherapy
in the treatment of patients with silicotuberculosis in
Hong Kong. Am Rev Respir Dis 1991;143:262-7.
- Hong Kong Chest Service/ British Medical Research Council.
Controlled trial of 2, 4, and 6 months of pyrazinamide in
6-month, three-times-weekly regimens for smear-positive
pulmonary tuberculosis, including an assessment of a combined
preparation of isoniazid, rifampicin, and pyrazinamide.
Results at 30 months. Am Rev Respir Dis 1991;143:700-6.
- Yew WW, Lee J, Chan CY, Cheung SW, Wong PC, Kwan SY. Ofloxacin
penetration into tuberculous pleural effusion. Antimicrob
Agents Chemother 1991;35:2159-60.
- Lau SK, Wei WI, Kwan S, Yew WW. Combined use of fine-needle
aspiration cytologic examination and tuberculin skin test
in the diagnosis of cervical tuberculous lymphadenitis.
A prospective study. Arch Otolaryngol Head Neck Surg 1991;117:87-90.
- Yew WW, Chan CY, Kwan SY, Cheung SW, French GL. Diagnosis
of tuberculous pleural effusion by the detection of tuberculostearic
acid in pleural aspirates. Chest 1991;100:1261-3.
- Chan SL. Advances in the Diagnosis of Tuberculosis. JAMA
SE Asia 1991;7:11-2.
- Yew WW, Kwan SY, Wong PC, Fu KH. Percutaneous transthoracic
needle biopsies in the rapid diagnosis of pulmonary tuberculosis.
Lung 1991;169:285-9.
- Walubo A, Chan K, Woo J, Chan HS, Wong CL. The disposition
of antituberculous drugs in plasma of elderly patients I.
Isoniazid and hydrazine metabolite. Methods Find Exp Clin
Pharmacol 1991;13:545-50.
- Walubo A, Chan K, Woo J, Chan HS, Wong CL. The disposition
of antituberculous drugs in plasma of elderly patients II.
Isoniazid, rifampicin and pyrazinamide. Methods Find Exp
Clin Pharmacol 1991;13:551-6.
- Chan CH, Arnold M, Chan CY, Mak TW, Hoheisel GB. Clinical
and pathological features of tuberculous pleural effusion
and its long-term consequences. Respiration 1991;58:171-5.
- Yew WW, Lau KS, Ling MH. Phenytoin toxicity in a patient
with isoniazid-induced hepatitis. Tubercle 1991;72:309-10.
返回頁首
|
|
